This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last?
by Zacks Equity Research
Biogen (BIIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BIIBPositive Net Change TARSPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Red Violet (RDVT) Moves 7.2% Higher: Will This Strength Last?
by Zacks Equity Research
Red Violet (RDVT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RDVTPositive Net Change RNGPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
AGNT (AGNT) Surges 7.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
AGNT (AGNT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AGNTPositive Net Change NMRKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last?
by Zacks Equity Research
ImmunityBio (IBRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IBRXNegative Net Change ACIUNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Genius Sports Limited (GENI) Moves 14.0% Higher: Will This Strength Last?
by Zacks Equity Research
Genius Sports Limited (GENI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GENIPositive Net Change YELPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Krystal Biotech (KRYS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KRYSPositive Net Change IMCRNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
ACI Worldwide (ACIW) Surges 5.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
ACI Worldwide (ACIW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ACIWPositive Net Change BLKBPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Lilly (LLY) Moves 7.1% Higher: Will This Strength Last?
by Zacks Equity Research
Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LLYPositive Net Change MRKPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Paycom (PAYC) Surges 3.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Paycom (PAYC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PAYCPositive Net Change VERXPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Qualys (QLYS) Soars 6.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Qualys (QLYS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
QLYSPositive Net Change CHKPPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today